{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3", "4-dicaffeoylquinic acid", "5-fold axis", "enterovirus-A71", "heparan sulphate"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35319229", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "23"}], "Language": ["eng"], "ELocationID": ["e00542-21", "10.1128/jvi.00542-21"], "Journal": {"ISSN": "1098-5514", "JournalIssue": {"Volume": "96", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "13"}}, "Title": "Journal of virology", "ISOAbbreviation": "J Virol"}, "ArticleTitle": "3,4-Dicaffeoylquinic Acid from the Medicinal Plant <i>Ilex kaushue</i> Disrupts the Interaction Between the Five-Fold Axis of Enterovirus A-71 and the Heparan Sulfate Receptor.", "Pagination": {"StartPage": "e0054221", "MedlinePgn": "e0054221"}, "Abstract": {"AbstractText": ["While infections by enterovirus A71 (EV-A71) are generally self-limiting, they can occasionally lead to serious neurological complications and death. No licensed therapies against EV-A71 currently exist. Using anti-virus-induced cytopathic effect assays, 3,4-dicaffeoylquinic acid (3,4-DCQA) from Ilex kaushue extracts was found to exert significant anti-EV-A71 activity, with a broad inhibitory spectrum against different EV-A71 genotypes. Time-of-drug-addition assays revealed that 3,4-DCQA affects the initial phase (entry step) of EV-A71 infection by directly targeting viral particles and disrupting viral attachment to host cells. Using resistant virus selection experiments, we found that 3,4-DCQA targets the glutamic acid residue at position 98 (E98) and the proline residue at position 246 (P246) in the 5-fold axis located within the VP1 structural protein. Recombinant viruses harboring the two mutations were resistant to 3,4-DCQA-elicited inhibition of virus attachment and penetration into human rhabdomyosarcoma (RD) cells. Finally, we showed that 3,4-DCQA specifically inhibited the attachment of EV-A71 to the host receptor heparan sulfate (HS), but not to the scavenger receptor class B member 2 (SCARB2) and P-selectin glycoprotein ligand-1 (PSGL1). Molecular docking analysis confirmed that 3,4-DCQA targets the 5-fold axis to form a stable structure with the E98 and P246 residues through noncovalent and van der Waals interactions. The targeting of E98 and P246 by 3,4-DCQA was found to be specific; accordingly, HS binding of viruses carrying the K242A or K244A mutations in the 5-fold axis was successfully inhibited by 3,4-DCQA.The clinical utility of 3,4-DCQA in the prevention or treatment of EV-A71 infections warrants further scrutiny. <b>IMPORTANCE</b> The canyon region and the 5-fold axis of the EV-A71 viral particle located within the VP1 protein mediate the interaction of the virus with host surface receptors. The three most extensively investigated cellular receptors for EV-A71 include SCARB2, PSGL1, and cell surface heparan sulfate. In the current study, a RD cell-based anti-cytopathic effect assay was used to investigate the potential broad spectrum inhibitory activity of 3,4-DCQA against different EV-A71 strains. Mechanistically, we demonstrate that 3,4-DCQA disrupts the interaction between the 5-fold axis of EV-A71 and its heparan sulfate receptor; however, no effect was seen on the SCARB2 or PSGL1 receptors. Taken together, our findings show that this natural product may pave the way to novel anti-EV-A71 therapeutic strategies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Emerging Viral Infections, College of Medicine, Chang Gung Universitygrid.145695.a, Kweishan, Taoyuan, Taiwan, PR China."}], "LastName": "Hsieh", "ForeName": "Chung-Fan", "Initials": "CF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung Universitygrid.145695.a, Kweishan, Taoyuan, Taiwan, PR China."}, {"Identifier": [], "Affiliation": "Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, grid.145695.a Taoyuan, Taiwan, PR China."}], "LastName": "Chen", "ForeName": "Yu-Li", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung Universitygrid.145695.a, Kweishan, Taoyuan, Taiwan, PR China."}], "LastName": "Lin", "ForeName": "Guan-Hua", "Initials": "GH"}, {"Identifier": ["0000-0001-7089-0510"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Microbiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia."}], "LastName": "Chan", "ForeName": "Yoke Fun", "Initials": "YF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Natural Products, College of Medicine, Chang Gung Universitygrid.145695.a, Taoyuan, Taiwan, PR China."}, {"Identifier": [], "Affiliation": "Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, grid.145695.a Taoyuan, Taiwan, PR China."}, {"Identifier": [], "Affiliation": "Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, PR China."}], "LastName": "Hsieh", "ForeName": "Pei-Wen", "Initials": "PW"}, {"Identifier": ["0000-0001-6294-9981"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Emerging Viral Infections, College of Medicine, Chang Gung Universitygrid.145695.a, Kweishan, Taoyuan, Taiwan, PR China."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung Universitygrid.145695.a, Kweishan, Taoyuan, Taiwan, PR China."}, {"Identifier": [], "Affiliation": "Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, grid.145695.a Taoyuan, Taiwan, PR China."}, {"Identifier": [], "Affiliation": "Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung Universitygrid.145695.a College of Medicine, Taoyuan, Taiwan, PR China."}], "LastName": "Horng", "ForeName": "Jim-Tong", "Initials": "JT"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Virol", "NlmUniqueID": "0113724", "ISSNLinking": "0022-538X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "318ADP12RI", "NameOfSubstance": "Chlorogenic Acid"}, {"RegistryNumber": "9050-30-0", "NameOfSubstance": "Heparitin Sulfate"}, {"RegistryNumber": "E57A0DKE0B", "NameOfSubstance": "3,4-di-O-caffeoylquinic acid"}], "CommentsCorrectionsList": [{"RefSource": "J Virol. 2022 Jun 8;96(11):e0064922. doi: 10.1128/jvi.00649-22", "PMID": "35575482"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Chlorogenic Acid"}, {"QualifierName": ["genetics"], "DescriptorName": "Enterovirus A, Human"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Enterovirus Infections"}, {"QualifierName": ["metabolism"], "DescriptorName": "Heparitin Sulfate"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ilex"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest. We have no conflicts of interest to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brown BA, Pallansch MA. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39:195\u2013205. 10.1016/0168-1702(95)00087-9.", "ArticleIdList": ["10.1016/0168-1702(95)00087-9", "8837884"]}, {"Citation": "Racaniello VR. 2007. Picornaviridae: the viruses and their replication, p 795\u2013838. In Knipe DavidM, Martin MalcolmA., Martin DianeE, Griffin RobertA, Lamb Bernard, Roizman, Straus Stephen E (ed), Fields virology, 5th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia."}, {"Citation": "Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274. 10.1126/science.1218713.", "ArticleIdList": ["10.1126/science.1218713", "PMC3448362", "22383808"]}, {"Citation": "Yamayoshi S, Fujii K, Koike S. 2014. Receptors for enterovirus 71. Emerg Microbes Infect 3:e53. 10.1038/emi.2014.49.", "ArticleIdList": ["10.1038/emi.2014.49", "PMC4126179", "26038749"]}, {"Citation": "Baggen J, Thibaut HJ, Strating J, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368\u2013381. 10.1038/s41579-018-0005-4.", "ArticleIdList": ["10.1038/s41579-018-0005-4", "29626210"]}, {"Citation": "Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798\u2013801. 10.1038/nm.1992.", "ArticleIdList": ["10.1038/nm.1992", "19543282"]}, {"Citation": "Koike S. 2009. [Identification of an enterovirus 71 receptor; SCARB2]. Uirusu 59:189\u2013194. 10.2222/jsv.59.189.", "ArticleIdList": ["10.2222/jsv.59.189", "20218327"]}, {"Citation": "Zhou D, Zhao Y, Kotecha A, Fry EE, Kelly JT, Wang X, Rao Z, Rowlands DJ, Ren J, Stuart DI. 2019. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol 4:414\u2013419. 10.1038/s41564-018-0319-z.", "ArticleIdList": ["10.1038/s41564-018-0319-z", "30531980"]}, {"Citation": "Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:3335\u20133347. 10.1128/JVI.02070-12.", "ArticleIdList": ["10.1128/JVI.02070-12", "PMC3592140", "23302872"]}, {"Citation": "Dang M, Wang X, Wang Q, Wang Y, Lin J, Sun Y, Li X, Zhang L, Lou Z, Wang J, Rao Z. 2014. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 5:692\u2013703. 10.1007/s13238-014-0087-3.", "ArticleIdList": ["10.1007/s13238-014-0087-3", "PMC4145081", "24986489"]}, {"Citation": "Zachos C, Blanz J, Saftig P, Schwake M. 2012. A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand beta-glucocerebrosidase. Traffic 13:1113\u20131123. 10.1111/j.1600-0854.2012.01372.x.", "ArticleIdList": ["10.1111/j.1600-0854.2012.01372.x", "22537104"]}, {"Citation": "Ho JY, Chern JH, Hsieh CF, Liu ST, Liu CJ, Wang YS, Kuo TW, Hsu SJ, Yeh TK, Shih SR, Hsieh PW, Chiu CH, Horng JT. 2016. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71. J Antimicrob Chemother 71:1922\u20131932. 10.1093/jac/dkw101.", "ArticleIdList": ["10.1093/jac/dkw101", "27098012"]}, {"Citation": "Tiwari V, Tarbutton MS, Shukla D. 2015. Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies. Molecules 20:2707\u20132727. 10.3390/molecules20022707.", "ArticleIdList": ["10.3390/molecules20022707", "PMC6272628", "25665065"]}, {"Citation": "Thacker BE, Xu D, Lawrence R, Esko JD. 2014. Heparan sulfate 3-O-sulfation: a rare modification in search of a function. Matrix Biol 35:60\u201372. 10.1016/j.matbio.2013.12.001.", "ArticleIdList": ["10.1016/j.matbio.2013.12.001", "PMC4039620", "24361527"]}, {"Citation": "Vlasak M, Goesler I, Blaas D. 2005. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 79:5963\u20135970. 10.1128/JVI.79.10.5963-5970.2005.", "ArticleIdList": ["10.1128/JVI.79.10.5963-5970.2005", "PMC1091682", "15857982"]}, {"Citation": "Zautner AE, Korner U, Henke A, Badorff C, Schmidtke M. 2003. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 77:10071\u201310077. 10.1128/jvi.77.18.10071-10077.2003.", "ArticleIdList": ["10.1128/jvi.77.18.10071-10077.2003", "PMC224569", "12941917"]}, {"Citation": "Zhang X, Shi J, Ye X, Ku Z, Zhang C, Liu Q, Huang Z. 2017. Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor. Emerg Microbes Infect 6:e65. 10.1038/emi.2017.55.", "ArticleIdList": ["10.1038/emi.2017.55", "PMC5567171", "28745308"]}, {"Citation": "Baggen J, Liu Y, Lyoo H, van Vliet ALW, Wahedi M, de Bruin JW, Roberts RW, Overduin P, Meijer A, Rossmann MG, Thibaut HJ, van Kuppeveld FJM. 2019. Bypassing pan-enterovirus host factor PLA2G16. Nat Commun 10:3171. 10.1038/s41467-019-11256-z.", "ArticleIdList": ["10.1038/s41467-019-11256-z", "PMC6639302", "31320648"]}, {"Citation": "Arita M, Wakita T, Shimizu H. 2008. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J Gen Virol 89:2518\u20132530. 10.1099/vir.0.2008/002915-0.", "ArticleIdList": ["10.1099/vir.0.2008/002915-0", "18796721"]}, {"Citation": "Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611\u2013620. 10.1128/JVI.02226-12.", "ArticleIdList": ["10.1128/JVI.02226-12", "PMC3536405", "23097443"]}, {"Citation": "Hsieh CF, Jheng JR, Lin GH, Chen YL, Ho JY, Liu CJ, Hsu KY, Chen YS, Chan YF, Yu HM, Hsieh PW, Chern JH, Horng JT. 2020. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors. Emerg Microbes Infect 9:1194\u20131205. 10.1080/22221751.2020.1767512.", "ArticleIdList": ["10.1080/22221751.2020.1767512", "PMC7448925", "32397909"]}, {"Citation": "Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341:929\u2013935. 10.1056/NEJM199909233411301.", "ArticleIdList": ["10.1056/NEJM199909233411301", "10498487"]}, {"Citation": "Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, Wong WR, Horng JT. 2009. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med 37:143\u2013158. 10.1142/S0192415X09006734.", "ArticleIdList": ["10.1142/S0192415X09006734", "19222118"]}, {"Citation": "Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. 2005. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci 78:82\u201390. 10.1016/j.lfs.2005.04.076.", "ArticleIdList": ["10.1016/j.lfs.2005.04.076", "PMC7094582", "16150462"]}, {"Citation": "Chen YL, Hwang TL, Yu HP, Fang JY, Chong KY, Chang YW, Chen CY, Yang HW, Chang WY, Hsieh PW. 2016. Ilex kaushue and its bioactive component 3,5-dicaffeoylquinic acid protected mice from lipopolysaccharide-induced acute lung injury. Sci Rep 6:34243. 10.1038/srep34243.", "ArticleIdList": ["10.1038/srep34243", "PMC5041076", "27681838"]}, {"Citation": "Nishimura Y, McLaughlin NP, Pan J, Goldstein S, Hafenstein S, Shimizu H, Winkler JD, Bergelson JM. 2015. The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate. PLoS Pathog 11:e1005184. 10.1371/journal.ppat.1005184.", "ArticleIdList": ["10.1371/journal.ppat.1005184", "PMC4592248", "26430888"]}, {"Citation": "Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. 2017. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 501:79\u201387. 10.1016/j.virol.2016.11.009.", "ArticleIdList": ["10.1016/j.virol.2016.11.009", "27875780"]}, {"Citation": "Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, Shimizu H. 2013. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog 9:e1003511. 10.1371/journal.ppat.1003511.", "ArticleIdList": ["10.1371/journal.ppat.1003511", "PMC3723564", "23935488"]}, {"Citation": "Zhou J, Yi H, Zhao ZX, Shang XY, Zhu MJ, Kuang GJ, Zhu CC, Zhang L. 2018. Simultaneous qualitative and quantitative evaluation of Ilex kudingcha C. J. Tseng by using UPLC and UHPLC-qTOF-MS/MS. J Pharm Biomed Anal 155:15\u201326. 10.1016/j.jpba.2018.02.037.", "ArticleIdList": ["10.1016/j.jpba.2018.02.037", "29605682"]}, {"Citation": "Cao Z, Ding Y, Cao L, Ding G, Wang Z, Xiao W. 2017. Isochlorogenic acid C prevents enterovirus 71 infection via modulating redox homeostasis of glutathione. Sci Rep 7:16278. 10.1038/s41598-017-16446-7.", "ArticleIdList": ["10.1038/s41598-017-16446-7", "PMC5701158", "29176678"]}, {"Citation": "Yuan S, Li G, Wang Y, Gao Q, Wang Y, Cui R, Altmeyer R, Zou G. 2016. Identification of positively charged residues in enterovirus 71 capsid protein VP1 essential for production of infectious particles. J Virol 90:741\u2013752. 10.1128/JVI.02482-15.", "ArticleIdList": ["10.1128/JVI.02482-15", "PMC4702679", "26512078"]}, {"Citation": "Meneghetti MC, Hughes AJ, Rudd TR, Nader HB, Powell AK, Yates EA, Lima MA. 2015. Heparan sulfate and heparin interactions with proteins. J R Soc Interface 12:e0589. 10.1098/rsif.2015.0589.", "ArticleIdList": ["10.1098/rsif.2015.0589", "PMC4614469", "26289657"]}, {"Citation": "Wang Y, Qing J, Sun Y, Rao Z. 2014. Suramin inhibits EV71 infection. Antiviral Res 103:1\u20136. 10.1016/j.antiviral.2013.12.008.", "ArticleIdList": ["10.1016/j.antiviral.2013.12.008", "24374150"]}, {"Citation": "Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH. 2012. Human SCARB2-mediated entry and endocytosis of EV71. PLoS One 7:e30507. 10.1371/journal.pone.0030507.", "ArticleIdList": ["10.1371/journal.pone.0030507", "PMC3260287", "22272359"]}, {"Citation": "Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, Mao L. 2018. Enterovirus A71 proteins: structure and function. Front Microbiol 9:286. 10.3389/fmicb.2018.00286.", "ArticleIdList": ["10.3389/fmicb.2018.00286", "PMC5826392", "29515559"]}, {"Citation": "Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, Su D, Ni C, Li J, Rao Z, Liu L, Lou Z. 2014. Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog 10:e1004422. 10.1371/journal.ppat.1004422.", "ArticleIdList": ["10.1371/journal.ppat.1004422", "PMC4183573", "25275585"]}, {"Citation": "Sun L, Lee H, Thibaut HJ, Lanko K, Rivero-Buceta E, Bator C, Martinez-Gualda B, Dallmeier K, Delang L, Leyssen P, Gago F, San-Felix A, Hafenstein S, Mirabelli C, Neyts J. 2019. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. PLoS Pathog 15:e1007760. 10.1371/journal.ppat.1007760.", "ArticleIdList": ["10.1371/journal.ppat.1007760", "PMC6590834", "31071193"]}, {"Citation": "Chang CW, Leu YL, Horng JT. 2012. Daphne genkwa Sieb. et Zucc. water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses 4:539\u2013556. 10.3390/v4040539.", "ArticleIdList": ["10.3390/v4040539", "PMC3347322", "22590685"]}, {"Citation": "Zhao L, Au JL, Wientjes MG. 2010. Comparison of methods for evaluating drug-drug interaction. Front Biosci (Elite Ed) 2:241\u2013249. 10.2741/e86.", "ArticleIdList": ["10.2741/e86", "PMC2885905", "20036874"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "23", "Hour": "12", "Minute": "13"}, {"Year": "2022", "Month": "9", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35319229", "PMC9006908", "10.1128/jvi.00542-21"]}}], "PubmedBookArticle": []}